Histone deacetylase inhibitors LBH589 and LAQ824 deplete Ezh2 and associated Polycomb Repressive Complex 2/3 proteins resulting in downregulation of HOXA9 and MEIS1 expression in human acute leukemia cells.

被引：0
|
作者：
Fiskus, W
Pranpat, M
Bali, P
Kumaraswamy, S
Boyapalle, S
Rocha, K
Balasis, M
Atadja, P
Bhalla, K
机构：
[1] H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL USA
[2] Novartis Pharmaceut, Cambridge, MA USA
来源：
BLOOD | 2005年 / 106卷 / 11期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
2482
引用
收藏
页码：697A / 697A
页数：1
相关论文
共 2 条
  • [1] Histone deacetylase inhibitors deplete Ezh2 and associated Polycomb Repressive Complex 2/3 proteins resulting in downregulation of HOXA9 and MEIS1 expression in human acute leukemia cells
    Fiskus, Warren
    Pranpat, Michael
    Bali, Purva
    Balasis, Maria
    Kumaraswamy, Sandhya
    Boyapalle, Sandhya
    Rocha, Kathy
    Atadja, Peter
    Bhalla, Kapil
    CANCER RESEARCH, 2006, 66 (08)
  • [2] Histone deacetylase inhibitors deplete enhancer of zeste 2 and associated polycomb repressive complex 2 proteins in human acute leukemia cells
    Fiskus, Warren
    Pranpat, Michael
    Balasis, Maria
    Herger, Bryan
    Rao, Rekha
    Chinnaiyan, Arul
    Atadja, Peter
    Bhalla, Kapil
    MOLECULAR CANCER THERAPEUTICS, 2006, 5 (12) : 3096 - 3104
1